ArticleCell death discovery2025

SPHK1 enhances olaparib resistance in ovarian cancer through the NFκB/NRF2/ferroptosis pathway.

Kai Teng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.